Please assess the completion status of the following clinical trial:

Trial Title: Prospective Controlled Study Evaluating Cryocontact Therapy of Infantile Hemangiomas of Preterm Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* preterm infants \<=34 weeks GA with hemangioma~Exclusion Criteria:~* no hemangioma

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 11 Weeks
- Healthy Volunteers: f

Study Arms:
- Cryocontact therapy (Type: EXPERIMENTAL): None
- Control (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).